Capecitabine
Common brands: Xeloda, Capecitabine 150mg, Capecitabine 500mg, Oxaliplatin, Avastin
Top reporter: H2-Pharma, Llc
Nucleoside Metabolic Inhibitor [EPC]Platinum-based Drug [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]HER2/neu Receptor Antagonist [EPC]Kinase Inhibitor [EPC]
90,021
Total Reports
39,515
Serious Reports
18,161
Death Reports
30
Reported Reactions
Death Report Ratio: High (20.17%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Capecitabine.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DIARRHOEA | 13,519 | |
| 2 | DEATH | 8,779 | |
| 3 | NAUSEA | 8,358 | |
| 4 | PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME | 6,616 | |
| 5 | FATIGUE | 6,404 | |
| 6 | VOMITING | 6,206 | |
| 7 | DISEASE PROGRESSION | 6,014 | |
| 8 | MALIGNANT NEOPLASM PROGRESSION | 3,901 | |
| 9 | OFF LABEL USE | 3,759 | |
| 10 | ASTHENIA | 3,363 | |
| 11 | DECREASED APPETITE | 3,220 | |
| 12 | NEUTROPENIA | 3,082 | |
| 13 | NEUROPATHY PERIPHERAL | 2,831 | |
| 14 | DEHYDRATION | 2,735 | |
| 15 | DYSPNOEA | 2,643 | |
| 16 | DRUG INEFFECTIVE | 2,605 | |
| 17 | THROMBOCYTOPENIA | 2,487 | |
| 18 | PYREXIA | 2,441 | |
| 19 | ANAEMIA | 2,352 | |
| 20 | ABDOMINAL PAIN | 2,239 | |
| 21 | RASH | 2,237 | |
| 22 | PAIN | 2,184 | |
| 23 | STOMATITIS | 2,085 | |
| 24 | WEIGHT DECREASED | 2,022 | |
| 25 | MUCOSAL INFLAMMATION | 1,974 | |
| 26 | CONSTIPATION | 1,880 | |
| 27 | METASTASES TO LIVER | 1,822 | |
| 28 | MALAISE | 1,752 | |
| 29 | PAIN IN EXTREMITY | 1,751 | |
| 30 | DIZZINESS | 1,605 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.